This topic contains a solution. Click here to go to the answer

Author Question: For a within-subjects study comparing two treatments, A and B, a researcher expects that practice in ... (Read 105 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
For a within-subjects study comparing two treatments, A and B, a researcher expects that practice in the first treatment will improve the participants' scores in the second treatment. If the order of treatments is counterbalanced, then the practice will ____.
 
  a. influence scores in treatment A, but not in treatment B
 b. influence scores in treatment B, but not in treatment A
 c. influence scores in treatment A for half the participants and scores in treatment B for half the participants
  d. not influence the scores in either treatment condition because the treatments are counterbalanced

Question 2

A yes-no question represents a(n) ____ response.
 
  a. interval response
  b. nominal
  c. multiple response
  d. ratio



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

c

Answer to Question 2

a





 

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library